Study of Helicobacter pylori infection in liver cirrhosis secondary to Hepatitis C Virus infection

Document Type : Original Article

Authors

1 Department of Internal Medicine, Faculty of Medicine, Beni Suef University, Egypt

2 Department of Internal Medicine, Beni Suef general Hospital, Egypt

Abstract

Helicobacter pylori is a microaerophile Gram-negative bacillus, resistant to the activity of gastric juice. The bacteria may take the vegetative form (spiral shape) or sporulation form .Liver cirrhosis and H.Pylori infection are two common diseases in our population and reducing the incidence of complications in cirrhotic subjects is an important step in current gastroenterology practice. The aim of the present study is to determine incidence of H. Pylori infection among patients with liver cirrhosis secondary to HCV infection and study the correlation between esophageal varices degree and H. Pylori infection. This study involved 50 patients with liver cirrhosis secondary to Hepatitis C Virus infection were selected from gastroenterology and internal medicine clinics at Beni-Suef general hospital and Beni-Suef university hospital. Our results illustrate that the percent of H. pylori infection among studied patients was 68%, our results illustrate that there is statistically significant association between the grade of varices and the detection of H. pylori; p value is less than 0.001.

Keywords

Main Subjects


  1. Brigitte M, Michelle N, Hubert (2020) . "Helicobacter pylori infection, a risk factor for Type 2 diabetes mellitus: a hospital-based cross-sectional study among dyspeptic patients in Douala-Cameroon. " National Library of Medicine 22;10(1):12141.
  2. Gutwerk A, Thomas W, Kerstin S, Cosima L, Ali C, Peter M, Alexander L et al (2018).'' Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism .Published online 2018 Mar 5. doi: 10.3390/jcm7030044.
  3. Hanafy, A. S., A. T. El Hawary, E. F. Hamed and A. M. Hassaneen). "Impact of Helicobacter pylori eradication on refractory thrombocytopenia in patients with chronic HCV awaiting antiviral therapy." Eur J Clin Microbiol Infect Dis 35(7): 1171-1176.
  4. Matsuo Y , Yasutoshi K, Yoshio Y (2017) Helicobacter pylori Outer Membrane Protein-Related Pathogenesis.'' Toxins (Basel). 2017 Mar; 9(3): 101.
  5. Mohamed Y, Ehsan H , Ghada H , Ibrahim A , Mohamed , Abdel-Aziz (2019) . "Molecular screening of Helicobacter pylori among Egyptian patients with decompensated Liver cirrhosis. "Journal of Bioscience and Applied Research, 2019, Vol.5, No. 4, P.533 -542.
  6. Okushin k, Takeya TKazuhiko kAkira KKenichiro EHidetaka FKyoji MHiroshi Y, Kazuhiko K (2018) .'' Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis.'' World Journal Gastroenterology 24(32): 3617–3625.
  7. Pogorzelska J , Magda ŁAlicja KTadeusz W Robert F (2017).'' Helicobacter pylori infection among patients with liver cirrhosis. ''European Journal of Gastroenterology & Hepatology (10):1161-1165.
  8. ZamaniM, Ebrahimtabar F ,,  Miller W ,  Alizadeh N ,J Shokri S ,  Derakhshan  M (2018) .'' Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection .''National Library of Medicine 47(7):868-876.